Recilisib
| CAS No. | 334969-03-8 | Cat. No. | BCP31296 |
| Name | Recilisib | ||
| Synonyms | Ex-RAD;ON-01210; ON01210; ON01210; | ||
| Formula | C16H13ClO4S | M. Wt | 336.79 |
| Description | Recilisib is a radioprotectant, which modifys cell cycle distribution patterns in cancer cells subjected to radiation therapy, and it has been identified as a potential candidate for radiation protection studies. It appears that Recilisib radioprotective mechanisms involve prevention of p53-dependent and independent radiation-induced apoptosis. | ||
| Pathways | PI3K/Akt/mTOR | ||
| Targets | PI3K AKT | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.